DnB Asset Management
RYTM icon

DnB Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

DnB Asset Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Buy
11,465
+270
+2% +$24.4K ﹤0.01% 630
2026
Q1 		$974K Buy
11,195
+32
+0.3% +$3.11K ﹤0.01% 649
2025
Q4 		$1.19M Buy
11,163
+5,635
+102% +$598K ﹤0.01% 628
2025
Q3 		$558K Buy
+5,528
New +$513K ﹤0.01% 668

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DnB Asset Management's RYTM Position: Q2 2026 in Review

DnB Asset Management increased its Rhythm Pharmaceuticals (RYTM) stake by 2.4% in Q2 2026, buying an estimated $24.4K and bringing the position to 11,465 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #630.

DnB Asset Management first reported a position in RYTM in Q3 2025 and has held it in 4 quarters since. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • DnB Asset Management held 11,465 shares of Rhythm Pharmaceuticals worth $1.27M as of Q2 2026.
  • DnB Asset Management bought 270 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $24.4K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of DnB Asset Management's portfolio in Q2 2026, its #630 holding.
  • DnB Asset Management first reported a position in Rhythm Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.